The first meta-analysis analyzed 70,361 participants from 10 randomized trials, and found those allocated to receive an SGLT2 ...

"Overall, the comprehensive meta-analysis highlights that SGLT2 inhibitors are effective across a wide range of kidney ...

The SGLT2 inhibitors market is driven by the rising prevalence of diabetes and demand for effective antidiabetic therapies ...

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.

Balcinrenone is similar to finerenone (Kerendia), which is also a nonsteroidal MRA and was approved for the slowing of ...

The combination therapy improved LVEF, quality of life, clinical outcomes, and more, but implementation questions remain.

In late-breaking presentations at the American Society of Nephrology Kidney Week meeting and simultaneously published in two ...

The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly ...

NEW ORLEANS, LA—Sodium-glucose cotransporter 2 (SGLT2) inhibition does not seem to be a solution to the problem of arrhythmia ...

Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and ...

A ketogenic diet may improve symptoms of depression, according to a new review and meta-analysis published in JAMA Psychiatry ...

To address knowledge gaps, investigators conducted a meta-analysis of more than 70,000 patients in 10 trials of SGLT2 inhibitors vs placebo to determine the relative risks of CKD progression across ...